Your browser is no longer supported. Please, upgrade your browser.
Settings
PRGO Perrigo Company plc daily Stock Chart
PRGO [NYSE]
Perrigo Company plc
IndexS&P 500 P/E- EPS (ttm)-0.95 Insider Own0.20% Shs Outstand143.07M Perf Week-3.35%
Market Cap12.68B Forward P/E11.40 EPS next Y7.77 Insider Trans-1.74% Shs Float137.16M Perf Month-2.56%
Income-134.70M PEG- EPS next Q1.59 Inst Own75.10% Short Float4.85% Perf Quarter-8.14%
Sales5.63B P/S2.25 EPS this Y-95.80% Inst Trans-6.28% Short Ratio2.75 Perf Half Y-29.60%
Book/sh69.14 P/B1.28 EPS next Y11.10% ROA-0.70% Target Price108.80 Perf Year-52.67%
Cash/sh- P/C- EPS next 5Y7.98% ROE-1.30% 52W Range82.37 - 189.19 Perf YTD-38.50%
Dividend0.58 P/FCF24.86 EPS past 5Y-59.80% ROI0.60% 52W High-53.16% Beta0.36
Dividend %0.65% Quick Ratio1.00 Sales past 5Y0.10% Gross Margin39.00% 52W Low7.58% ATR2.35
Employees13242 Current Ratio1.40 Sales Q/Q-3.30% Oper. Margin0.50% RSI (14)44.75 Volatility2.74% 2.35%
OptionableYes Debt/Eq0.65 EPS Q/Q251.30% Profit Margin-2.40% Rel Volume1.30 Prev Close88.48
ShortableYes LT Debt/Eq0.57 EarningsAug 10 BMO Payout- Avg Volume2.42M Price88.61
Recom2.90 SMA20-1.98% SMA50-3.58% SMA200-25.69% Volume3,146,795 Change0.15%
Aug-11-16Reiterated Barclays Overweight $120 → $110
Jul-22-16Upgrade Deutsche Bank Hold → Buy $115
Jun-20-16Downgrade Argus Buy → Hold
Apr-26-16Reiterated RBC Capital Mkts Sector Perform $140 → $109
Apr-26-16Reiterated Barclays Overweight $180 → $120
Apr-25-16Downgrade Wells Fargo Outperform → Market Perform
Apr-25-16Downgrade BofA/Merrill Buy → Underperform
Feb-22-16Downgrade Goldman Neutral → Sell
Feb-19-16Initiated Wells Fargo Outperform
Feb-19-16Downgrade B. Riley & Co. Buy → Neutral $239 → $146
Jan-21-16Initiated Barclays Overweight $180
Dec-10-15Upgrade Argus Hold → Buy $170
Dec-03-15Initiated Morgan Stanley Equal-Weight
Nov-24-15Reiterated B. Riley & Co. Buy $229 → $237
Nov-18-15Resumed JP Morgan Neutral
Nov-16-15Upgrade UBS Neutral → Buy $200
Oct-23-15Reiterated B. Riley & Co. Neutral $218 → $229
Jun-03-15Reiterated B. Riley & Co. Neutral $195 → $216
Apr-27-15Downgrade B. Riley & Co. Buy → Neutral
Apr-22-15Reiterated B. Riley & Co. Buy $189 → $195
Aug-25-16 01:29PM  [$$] Mylan: pen is not mightier at Financial Times
11:22AM  How Mylan's EpiPen Fight Could Sting Investors at The Wall Street Journal
Aug-24-16 07:50AM  10 Stocks Billionaire David Einhorn Loves in 2016
Aug-23-16 11:04AM  Will Anda Acquisition Improve Access to Tevas Generic Drugs?
09:10AM  Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep® Oral Solution And Confirms Patent Challenge For Generic Version Of Mirvaso® Gel PR Newswire
Aug-19-16 11:25AM  What Are Analysts Recommending for Teva Pharmaceutical in 2016?
Aug-17-16 11:04AM  How Did Valeant Manage Its Operating Expenses in 2Q16?
07:46AM  Perrigo to Acquire U.S. Distributor of Healthcare & Consumer Goods Products, Geiss, Destin & Dunn PR Newswire
Aug-16-16 07:00AM  Our Ultimate Stock-Pickers Top 10 New-Money Purchases at Morningstar
Aug-15-16 09:15AM  Post Earnings Coverage as Perrigo Doubles Profit
Aug-14-16 07:18AM  3 Beaten-Up Big Pharma Stocks: Are They Bargains? at Motley Fool
Aug-12-16 11:05AM  What Are Valeants New Segments?
Aug-11-16 02:12PM  Deutsche Thinks Perrigo's Lowered Expectations Are Beatable
01:04PM  ETFs with exposure to Perrigo Co. Plc : August 11, 2016
10:44AM  Perrigo: A High Price to Pay for Uncertainty at Barrons.com
10:10AM  Stock Market News for August 11, 2016
09:56AM  Perrigo (PRGO) Stock Slumps, Price Target Cut at Deutsche Bank
Aug-10-16 11:16PM  [$$] Business Watch at The Wall Street Journal -9.56%
04:39PM  Edited Transcript of PRGO earnings conference call or presentation 10-Aug-16 12:30pm GMT
04:16PM  Perrigo Company plc -- Moody's affirms Perrigo's Baa3 rating; changes outlook to negative at Moody's
01:28PM  Cant stomach volatile Valeant shares? Analysts like its bonds better at MarketWatch
01:26PM  Good, bad, & ugly: HBI, airlines & PRGO
01:01PM  More Squawk from Jim Cramer: Perrigo (PRGO) Quarter Was 'Problematic'
12:58PM  Perrigo Has a Warning for Valeant at Bloomberg
12:50PM  Many 52-Week Lows, Even as Stock Market at All-Time Highs: SunPower, Myriad, Perrigo, Tidewater and More at 24/7 Wall St.
12:48PM  Why Hendrickson-Led Perrigo Is A Good Bet For Long Term Investors
12:48PM  Jim Cramer: Perrigo is Problematic at TheStreet
10:49AM  Perrigo (PRGO) Misses Q2 Earnings Estimates, Cuts '16 View
10:36AM  Why I Feel Bearish About the Market
10:33AM  Don't 'Catch a Falling Knife' with Perrigo
09:53AM  US STOCKS-Wall St flat as investors pause after record-setting day
09:13AM  The Market In 5 Minutes: Stocks Still In Tight Range, Disney And Michael Kors Fall On Earnings
08:41AM  Perrigo (PRGO) Stock Slumps on Q2 Earnings Miss, Downbeat Guidance
08:33AM  Morning Movers: Myriad Genetics Craters on Guidance; Disney Drops at Barrons.com
08:08AM  [$$] Perrigo Misses Expectations and Cuts Guidance at The Wall Street Journal
08:07AM  Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : August 10, 2016
07:07AM  Q2 2016 (Calendar) Perrigo Company PLC Earnings Release - 06:00 am ET
06:57AM  Perrigo (PRGO) Misses on Q2 Earnings, Lowers View
06:42AM  PERRIGO CO PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
06:39AM  Perrigo misses 2Q profit forecasts
06:29AM  Perrigo Company plc Reports Second Quarter 2016 Financial Results PR Newswire
Aug-09-16 03:29PM  Perrigo (PRGO) Stock Gains Ahead of Tomorrow's Q2 Results
12:42PM  Valeant Hangs on but Debt Pressures Remain
10:42AM  Valeant Shares Rally on Outlook, but Analysts Say Debt Worries Still Loom
08:32AM  Medical Products' Earnings on Aug 10: PRGO, NVTR & BSGM
Aug-08-16 10:25AM  Perrigo (PRGO) Q2 Earnings: Stock Likely to Disappoint?
08:12AM  Perrigo Completes The Divestiture Of Its Vitamins, Minerals & Supplements Business To IVC PR Newswire
Aug-05-16 07:00PM  Jim Cramer's 'Mad Money' Recap: I'm Watching These Stocks Next Week
04:35PM  PERRIGO CO PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
11:04AM  An Update on Analysts Recommendations for Mallinckrodt
09:05AM  Falls Continue in Specialty Generics and Nuclear Imaging
Aug-04-16 06:42PM  Healthcare Dividend Growth Stocks: Part 1
Aug-03-16 03:39PM  Mallinckrodts Strong Fiscal 3Q16 Impressed Wall Street
03:08PM  How Analysts Are Rating Valeant before Its Q216 Earnings
01:25PM  Keeley Funds Comment on Perrigo Co.
Aug-02-16 11:59AM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
Jul-27-16 05:41PM  Teva, Allergan win U.S. antitrust approval for generics deal Reuters
11:08AM  Factors That Could Lead to More Growth for Acthar
07:59AM  Perrigo Company plc To Release Second Quarter Calendar Year 2016 Results On August 10, 2016 PR Newswire
Jul-26-16 12:52PM  Jerome Dodson Comments on Perrigo
12:41PM  Jerome Dodson's Parnassus Fund 2nd Quarter Commentary
Jul-22-16 12:54PM  Perrigo upgraded by Deutsche Bank
07:33AM  It's Time to Sell These 5 Big Stocks This Summer
Jul-20-16 08:55PM  Perrigo Announces Leadership Change in Rx Pharmaceuticals Segment PR Newswire
Jul-19-16 02:48PM  Perrigo Co. Plc Value Analysis (NYSE:PRGO) : July 19, 2016
08:22AM  5 Big Pharma Stocks Struggling to Raise Their Dividends at Motley Fool
Jul-18-16 08:51AM  Perrigo Announces FDA Final Approval And Launch Of The Store Brand Equivalent To Zegerid OTC® Capsules PR Newswire
Jul-16-16 11:06AM  PERRIGO SHAREHOLDER JULY 18 DEADLINE: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces the Filing of a Securities Class Action Lawsuit Against Perrigo Company plc; Encourages Investors to Contact the Firm PR Newswire
Jul-15-16 10:07PM  PERRIGO 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Perrigo Company plc - PRGO GlobeNewswire
07:48PM  July 18 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against Perrigo Company plc Business Wire
02:41PM  Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Perrigo Company plc Investors and Encourages Investors to Contact the Firm Business Wire
09:00AM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Perrigo Company plc of Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2016 PRGO GlobeNewswire
Jul-14-16 12:41PM  SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Perrigo Company plc and Encourages Investors with Losses to Contact the Firm Business Wire
09:13AM  Valeant's Ex-CEO Michael Pearson Sells Nearly $100 Million in Company Stock at The Wall Street Journal
12:20AM  Valeants Ex-CEO Michael Pearson Sells Nearly $100 Million in Company Stock at The Wall Street Journal
Jul-13-16 07:36PM  Valeants former CEO dumped $100 million in stock in past 2 weeks at MarketWatch
01:48PM  David Rolfe Comments on Perrigo
10:30AM  The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Perrigo Company plc Investors and Encourages Investors to Contact the Firm Business Wire
08:52AM  Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : July 13, 2016
Jul-12-16 04:27PM  Pricing Stress may Weigh on Generic Drugmakers Ahead of Q2 Earnings
01:42PM  David Rolfe's Wedgewood Partners 2nd Quarter 2016 Client Letter
11:59AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Perrigo Company plc (PRGO) & Lead Plaintiff Deadline: July 18, 2016 Accesswire
Jul-11-16 12:29PM  APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Perrigo Company plc and Reminds Investors with Losses to Contact the Firm Business Wire
11:14AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Perrigo Company plc of Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2016 Business Wire
Jul-08-16 08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Perrigo Company plc of Class Action Lawsuit and Upcoming Deadline PRGO GlobeNewswire
Jul-06-16 01:04AM  [$$] Valeants New CEO Brings Familiar Prescription at The Wall Street Journal
Jul-05-16 06:22PM  [$$] Valeant's New CEO Brings Familiar Prescription at The Wall Street Journal
04:29PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Perrigo Company plc and Reminds Investors with Losses to Contact the Firm Business Wire
03:20PM  Bill Ackman's Pershing Square Fund Goes Into the Red
10:45AM  PRGO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Perrigo Company plc and a Lead Plaintiff Deadline of July 18, 2016 Business Wire
Jul-01-16 10:13PM  INVESTOR NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit against Perrigo Company plc and Encourages Investors with Losses to Contact the Firm Business Wire
10:07PM  PERRIGO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Perrigo Company plc - PRGO PR Newswire
05:33PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Perrigo Company plc of Class Action Lawsuit and Upcoming Deadline - PRGO PR Newswire
10:43AM  Alternate Dosage Forms Are Expected to Drive Akorns Growth in 2016
Jun-29-16 04:43PM  INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Perrigo Company plc and a Lead Plaintiff Deadline of July 18, 2016 - PRGO PR Newswire
Jun-27-16 06:38AM  PERRIGO CO PLC Files SEC form 8-K, Other Events
Jun-24-16 11:30PM  DEADLINE ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Perrigo Company plc and Reminds Investors with Losses to Contact the Firm Accesswire
09:15PM  DEADLINE ALERT: Brower Piven Reminds Shareholders of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess of $100,000 From Investment In Perrigo Company plc To Contact The Firm Business Wire
11:02AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Perrigo Company plc of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2016 Business Wire
Jun-23-16 05:05PM  SHAREHOLDER NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Perrigo Company plc and Reminds Investors with Losses to Contact the Firm Business Wire
Perrigo Company plc, together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. The company operates through Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences, and Other segments. The CHC segment offers OTC products in various categories, including analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritional, smoking cessation, animal health, feminine hygiene, diabetes and dermatological care, diagnostic, scar management, and other healthcare products, as well as vitamins, minerals, and dietary supplements (VMS); and contract manufacturing services. It serves retail drug, supermarket, mass merchandise chains, and wholesalers through sales force and industry brokers. The BCH segment provides branded OTC products in the natural health and VMS; cough, cold, flu, and allergy; personal care and derma-therapeutics; lifestyle; pain relief, nasal decongestants, and cold sore management; and anti-parasite areas, as well as offers generic pharmaceutical products. It serves pharmacies, drug, and grocery stores through pharmacy sales force, as well as a network of pharmacists. The Rx segment offers generic and specialty pharmaceutical prescription drugs in various dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, women's health products, oral solid dosage forms, and oral liquid formulations; and ORx products. It serves wholesalers; retail drug, supermarket, and mass merchandise chains; hospitals; and pharmacies. The Specialty Sciences segment offers Tysabri to treat multiple sclerosis. The Other segment offers active pharmaceutical ingredients used by generic and branded pharmaceutical companies. The company was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weninger PaulEVP, Quality OperationsAug 22Option Exercise91.5218817,2062,296Aug 24 03:54 PM
Brown Judy LEVP, Business Ops & CFOAug 22Option Exercise91.522,877263,30319,717Aug 24 03:53 PM
Farrington ThomasEVP and CIOAug 22Option Exercise91.5269363,4234,299Aug 24 03:53 PM
Quinn GrainneEVP, Chief Medical OfficerAug 22Option Exercise91.522,168198,4153,208Aug 24 03:53 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 22Option Exercise91.521,336122,27111,327Aug 24 03:52 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainAug 22Option Exercise91.5230127,5481,586Aug 24 03:52 PM
HENDRICKSON JOHN TCEOAug 22Option Exercise91.521,536140,5755,401Aug 24 03:52 PM
Kochan SharonEVP, GM InternationalAug 22Option Exercise91.521,336122,27110,088Aug 24 03:51 PM
KINGMA TODD WExecutive VP, General CounselAug 22Option Exercise91.521,536140,57515,796Aug 23 04:58 PM
KINGMA TODD WExecutive VP, General CounselAug 19Option Exercise91.831,692155,37612,012Aug 23 04:58 PM
Kochan SharonEVP, GM InternationalAug 19Option Exercise91.831,01593,2076,898Aug 23 04:57 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 19Option Exercise91.8333831,0397,678Aug 23 04:57 PM
Farrington ThomasEVP and CIOAug 19Option Exercise91.831,692155,3762,886Aug 23 04:57 PM
HENDRICKSON JOHN TCEOAug 19Option Exercise91.831,692155,3761,692Aug 23 04:56 PM
Brown Judy LEVP, Business Ops & CFOAug 19Option Exercise91.831,692155,37614,121Aug 23 04:58 PM
JANDERNOA MICHAEL JDirectorMay 04Option Exercise95.7092488,4278,774May 06 04:23 PM
MORRIS HERMAN JRDirectorMay 04Option Exercise95.7092488,4275,055May 06 04:23 PM
FOUSE JACQUALYN ADirectorMay 04Option Exercise95.7092488,4274,360May 06 04:24 PM
COHEN GARY MDirectorMay 04Option Exercise95.7092488,42713,795May 06 04:24 PM
Yanai ShlomoDirectorMay 04Option Exercise95.7092488,427924May 06 04:22 PM
BRLAS LAURIEDirectorMay 04Option Exercise95.7092488,42710,901May 06 04:22 PM
KUNKLE GARY K JRDirectorMay 04Option Exercise95.7092488,42726,131May 06 04:23 PM
Hoffing Ellen RandiDirectorMay 04Option Exercise95.7092488,4279,528May 06 04:24 PM
Brown Judy LExecutive VP & CFOApr 13Option Exercise113.772,776315,82513,924Apr 14 03:38 PM
Brown Judy LExecutive VP & CFOApr 13Sale126.222,776350,38712,429Apr 14 03:38 PM
JANDERNOA MICHAEL JDirectorMar 18Option Exercise16.775,81497,5018,611Mar 22 04:31 PM
JANDERNOA MICHAEL JDirectorMar 18Sale128.2976197,6297,850Mar 22 04:31 PM
Kochan SharonEVP, GM InternationalMar 02Sale125.281,490186,6675,883Mar 04 02:43 PM
Brown Judy LExecutive VP & CFOFeb 24Option Exercise113.772,776315,82513,924Feb 26 03:07 PM
Brown Judy LExecutive VP & CFOFeb 24Sale123.732,776343,47412,429Feb 26 03:07 PM
PERRIGO Co plc10% OwnerFeb 17Buy8.00125,0001,000,0002,908,067Feb 18 05:50 PM
Brown Judy LExecutive VP & CFOJan 06Option Exercise83.1227,7372,305,62426,518Jan 08 03:27 PM
Brown Judy LExecutive VP & CFOJan 06Sale142.4127,7373,950,07512,429Jan 08 03:27 PM
PAPA JOSEPH CCEODec 28Option Exercise58.8210,183598,964129,598Dec 30 03:18 PM
PAPA JOSEPH CCEODec 28Sale147.0710,1831,497,579119,415Dec 30 03:18 PM
Farrington ThomasEVP and CIONov 30Sale151.0335052,8611,194Dec 02 09:29 AM
Gottfried RanDirectorNov 19Option Exercise100.842,726274,89015,454Nov 23 04:17 PM
Gottfried RanDirectorNov 19Sale154.342,726420,72212,728Nov 23 04:17 PM
MORRIS HERMAN JRDirectorNov 18Sale155.6455085,602850Nov 20 07:35 PM
KUNKLE GARY K JRDirectorNov 13Option Exercise146.901,929283,37026,133Nov 17 04:57 PM
JANDERNOA MICHAEL JDirectorNov 13Option Exercise146.901,929283,3702,797Nov 17 04:57 PM
BRLAS LAURIEDirectorNov 13Option Exercise146.901,929283,37010,903Nov 17 04:58 PM
Hoffing Ellen RandiDirectorNov 13Option Exercise146.901,929283,3709,530Nov 17 04:56 PM
FOUSE JACQUALYN ADirectorNov 13Option Exercise146.901,929283,3704,362Nov 17 04:56 PM
COHEN GARY MDirectorNov 13Option Exercise146.901,929283,37013,797Nov 17 04:56 PM
MORRIS HERMAN JRDirectorNov 13Option Exercise146.901,929283,3705,057Nov 17 04:57 PM
O'Connor DonalDirectorNov 13Option Exercise146.901,929283,3702,173Nov 17 04:57 PM
GIBBONS DAVID TDirectorNov 04Option Exercise162.291,929313,05715,104Nov 05 04:16 PM
Gottfried RanDirectorNov 04Option Exercise162.291,929313,05713,654Nov 06 05:22 PM